Physiological Status Unaffected by Blood Storage Duration
|
By LabMedica International staff writers Posted on 07 Feb 2012 |
|
Alterations to both red blood cells (RBC) and their media during the storage process are potentially responsible for many of the adverse effects associated with RBC administration.
The impact of RBC storage duration has been evaluated on short-term pulmonary function and immunologic status in mechanically ventilated patients receiving RBC transfusion.
Scientists at the Mayo Clinic (Rochester, MN, USA) conducted a double-blind trial, where 50 patients were randomized to receive fresh RBC with a median storage duration of four days and 50 patients were randomized to receive standard issue RBC with a median storage duration of 26.5 days. All RBC units underwent prestorage leukoreduction. All the patients were mechanically ventilated in the intensive care unit (ICU).
The primary outcome measure of change was in pulmonary function arterial oxygen tension - fractional inspired oxygen (PaO2/FiO2) ratio. Other outcome measures included the immunologic status by estimating levels of tumor necrosis factor-alpha, interleukin-8, C-reactive protein and the coagulation status by measuring fibrinogen, anti-thrombin consumption. Measurements were obtained at baseline and within two hours of the completion of RBC transfusion.
No significant differences between groups were seen in the primary outcome measure of change in PaO2/FiO2 ratio: fresh RBC was 2.5 ± 49.3 and standard issue RBC was -9.0 ± 69.8. Similarly, no significant differences were seen for any of the other outcome measures of pulmonary function such as fraction of dead space ventilation, dynamic and static pulmonary compliance or the immunologic and coagulation status measurements.
Daryl J. Kor, MD, assistant professor of anesthesiology at the Mayo Clinic College of Medicine, said, "Our data do not support a significant effect of RBC storage duration on respiratory, immunologic or coagulation parameters in the immediate posttransfusion period. Previous observational studies linking RBC storage duration and respiratory complications may have suffered from bias and unmeasured confounding, which were more effectively addressed in our double-blind, randomized trial study design." The study was published online on January 26, 2012 in the American Journal of Respiratory and Critical Care Medicine.
Related Links:
Mayo Clinic
The impact of RBC storage duration has been evaluated on short-term pulmonary function and immunologic status in mechanically ventilated patients receiving RBC transfusion.
Scientists at the Mayo Clinic (Rochester, MN, USA) conducted a double-blind trial, where 50 patients were randomized to receive fresh RBC with a median storage duration of four days and 50 patients were randomized to receive standard issue RBC with a median storage duration of 26.5 days. All RBC units underwent prestorage leukoreduction. All the patients were mechanically ventilated in the intensive care unit (ICU).
The primary outcome measure of change was in pulmonary function arterial oxygen tension - fractional inspired oxygen (PaO2/FiO2) ratio. Other outcome measures included the immunologic status by estimating levels of tumor necrosis factor-alpha, interleukin-8, C-reactive protein and the coagulation status by measuring fibrinogen, anti-thrombin consumption. Measurements were obtained at baseline and within two hours of the completion of RBC transfusion.
No significant differences between groups were seen in the primary outcome measure of change in PaO2/FiO2 ratio: fresh RBC was 2.5 ± 49.3 and standard issue RBC was -9.0 ± 69.8. Similarly, no significant differences were seen for any of the other outcome measures of pulmonary function such as fraction of dead space ventilation, dynamic and static pulmonary compliance or the immunologic and coagulation status measurements.
Daryl J. Kor, MD, assistant professor of anesthesiology at the Mayo Clinic College of Medicine, said, "Our data do not support a significant effect of RBC storage duration on respiratory, immunologic or coagulation parameters in the immediate posttransfusion period. Previous observational studies linking RBC storage duration and respiratory complications may have suffered from bias and unmeasured confounding, which were more effectively addressed in our double-blind, randomized trial study design." The study was published online on January 26, 2012 in the American Journal of Respiratory and Critical Care Medicine.
Related Links:
Mayo Clinic
Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
New
Lyme Disease Test
Lyme IgG/IgM Rapid Test Cassette
New
Troponin I Test
Quidel Triage Troponin I Test
Latest Hematology News
- New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
- Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
- WBC Count Could Predict Severity of COVID-19 Symptoms
- New Platelet Counting Technology to Help Labs Prevent Diagnosis Errors
- Streamlined Approach to Testing for Heparin-Induced Thrombocytopenia Improves Diagnostic Accuracy
- POC Hemostasis System Could Help Prevent Maternal Deaths
- New Test Assesses Oxygen Delivering Ability of Red Blood Cells by Measuring Their Shape
- Personalized CBC Testing Could Help Diagnose Early-Stage Diseases in Healthy Individuals
- Non-Invasive Test Solution Determines Fetal RhD Status from Maternal Plasma
- First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC
- Next Gen CBC and Sepsis Diagnostic System Targets Faster, Earlier, Easier Results
- Newly Discovered Blood Group System to Help Identify and Treat Rare Patients
- Blood Platelet Score Detects Previously Unmeasured Risk of Heart Attack and Stroke
- Automated Benchtop System to Bring Blood Testing To Anyone, Anywhere
- New Hematology Analyzers Deliver Combined ESR and CBC/DIFF Results in 60 Seconds
- Next Generation Instrument Screens for Hemoglobin Disorders in Newborns
Channels
Clinical Chemistry
view channel
Carbon Nanotubes Help Build Highly Accurate Sensors for Continuous Health Monitoring
Current sensors can measure various health indicators, such as blood glucose levels, in the body. However, there is a need to develop more accurate and sensitive sensor materials that can detect lower... Read more
Paper-Based Device Boosts HIV Test Accuracy from Dried Blood Samples
In regions where access to clinics for routine blood tests presents financial and logistical obstacles, HIV patients are increasingly able to collect and send a drop of blood using paper-based devices... Read more
Molecular Diagnostics
view channel
RNA-Based Blood Test Detects Preeclampsia Risk Months Before Symptoms
Preeclampsia remains a major cause of maternal morbidity and mortality, as well as preterm births. Despite current guidelines that aim to identify pregnant women at increased risk of preeclampsia using... Read more
First Of Its Kind Test Uses microRNAs to Predict Toxicity from Cancer Therapy
Many men with early-stage prostate cancer receive stereotactic body radiotherapy (SBRT), a highly precise form of radiation treatment that is completed in just five sessions. Compared to traditional radiation,... Read more
Novel Cell-Based Assay Provides Sensitive and Specific Autoantibody Detection in Demyelination
Anti-myelin-associated glycoprotein (MAG) antibodies serve as markers for an autoimmune demyelinating disorder that affects the peripheral nervous system, leading to sensory impairment. Anti-MAG-IgM antibodies... Read more
Immunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read more
Microbiology
view channel
Handheld Device Deliver Low-Cost TB Results in Less Than One Hour
Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more
New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
Drug-resistant infections, particularly those caused by deadly bacteria like tuberculosis and staphylococcus, are rapidly emerging as a global health emergency. These infections are more difficult to treat,... Read more
Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Pathology
view channel
Advanced Imaging Reveals Mechanisms Causing Autoimmune Disease
Myasthenia gravis, an autoimmune disease, leads to muscle weakness that can affect a range of muscles, including those needed for basic actions like blinking, smiling, or moving. Researchers have long... Read more
AI Model Effectively Predicts Patient Outcomes in Common Lung Cancer Type
Lung adenocarcinoma, the most common form of non-small cell lung cancer (NSCLC), typically adopts one of six distinct growth patterns, often combining multiple patterns within a single tumor.... Read more
Technology
view channel
Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more
Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
Viruses present a major global health risk, as demonstrated by recent pandemics, making early detection and identification essential for preventing new outbreaks. While traditional detection methods are... Read more
Industry
view channel
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more
